COVID-19-RELATED VACCINES AND THERAPEUTICS;PRELIMINARY INSIGHTS ON RELATED PATENTING ACTIVITY DURING THE PANDEMIC
Since the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-COV-2 virus and the related disease. This patent landscape report provides early observations on the patenting activity which took place in the field of COVID-19 vaccines and therape...
Saved in:
| Format: | Electronic eBook |
|---|---|
| Language: | English |
| Published: |
[S.l.] :
WORLD INTELLECTUAL PROPER,
2022.
|
| Series: | Patent landscape report
|
| Subjects: | |
| Online Access: | EBSCOhost |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Intro
- _Hlk93048502
- Acknowledgements
- Key findings
- Introduction
- Background
- biology of COVID-19
- Overview of patenting activity related to COVID-19
- Patent filings during 2020-2021
- Filing and publication of COVID-19-related patent applications over time
- COVID-19-related vaccine and therapeutic patent applicant profiles
- Research collaboration and IP strategies related to technologies important to COVID-19 vaccines and therapeutics
- Disclosure of sequences within patent documents
- COVID-19 vaccines
- Background
- vaccine platforms
- Conventional vaccine platforms
- Novel vaccine platforms
- Patent and vaccine distribution by vaccine platform and published applicant location
- Speed of vaccine development
- COVID-19 vaccine patent landscape
- Core vaccine technologies, collaboration and licensing
- Analysis of WHO data on COVID-19 vaccines
- Timelines on key technologies for COVID-19 vaccine development
- Technologies relevant to mRNA vaccine
- Timeline details for adenovirus vaccine development
- Timeline details for vaccine adjuvant development
- COVID-19 therapeutics
- Background
- Analysis of COVID-19 therapeutics-related patent applications by substances type
- Top locations of patent applicants for COVID-19 therapeutics and their filing strategies
- Highlights of patent filings related to COVID-19 therapeutic development
- Patent filings related to development of small-molecule drugs for COVID-19
- Patent filings related to the development of biologics for COVID-19
- Patents related to antibodies for COVID-19 treatment
- Peptide and protein therapies
- Nucleic-acid-based therapies
- Aptamer-mediated therapy
- Cell-based therapies
- Other biologic-based therapies
- Analysis of COVID-19 therapeutics in clinical trials.
- Analysis of COVID-19 therapeutics data in the Milken Institute and Regulatory Affairs Professionals Society (RAPS) tracker data
- Distribution of COVID-19 drug candidates across small molecules and biologics, repurposed drugs and de novo synthesized drugs
- Classification of COVID-19 drug candidates in clinical trials by molecular nature and function
- Feature summary of examples of anti-COVID-19 drug candidates in clinical trials
- Perspectives
- Annex
- Data sources and methods
- Tables of vaccine types and candidates currently in clinical trials
- Examples of partial, early disclosure observed at the Israeli, U.K. and Singapore patent offices
- Glossary
- References
- Further reading.